Use of pramipexole

PDMED_PRAMIPEXOLE

No definition available.

Endpoint definition

FinnGen phenotype data

321302 individuals

diagram downward connector

Apply sex-specific rule None

321302

diagram downward connector

Check conditions None

321302

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC N04BC05

9243

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

4899

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

4899

diagram downward connector

Include endpoints None

4899

diagram downward connector
PDMED_PRAMIPEXOLE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
?
Number of individuals
4778 2937 1841
?
Unadjusted prevalence (%)
1.55 1.69 1.36
?
Mean age at first event (years)
61.73 60.57 63.59

?
Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.04 3.09 [2.34, 4.09] 2.2e-15 531
15 years 0.01 1.82 [1.37, 2.41] 3.1e-5 289
5 years 0.00 3.45 [2.76, 4.32] 1.2e-27 207
1 year 0.00 2.14 [1.39, 3.28] 5.0e-4 25

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: PDMED_PRAMIPEXOLE – Use of pramipexole
GWS hits:

Survival analyses between endpoints

Plot

before Use of pramipexole
after Use of pramipexole

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of pramipexole